NCT02866565View on ClinicalTrials.gov

Assessment of the Efficacy and Tolerance of Sub-cutaneous Re-injection of Autologous Adipose-derived REGEnerative Cells in the Local Treatment of Neuropathic Diabetic Foot ulcERs

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

June 30, 2023

Primary Completion Date

September 30, 2026

Study Completion Date

December 31, 2026

Conditions
Diabetic Foot Ulcer
Interventions
DRUG

adipose-derived regenerative cells (ADRCs)

injection of the experimental treatment

Trial Locations (1)

Unknown

Assistance Publique Hopitaux de Marseille, Marseille

All Listed Sponsors
lead

Assistance Publique Hopitaux De Marseille

OTHER